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Predicting the effect of improved socioeconomic health 
determinants on the tuberculosis epidemic
Two important public health documents have recently 
established programmatic goals for tuberculosis control. 
The first is WHO’s End TB Strategy, which represents 
the evolution of previous DOTS (directly observed 
treatment, short-course) and Stop TB strategies.1 End TB 
is built around three pillars: pillar 1 focuses on diagnosis, 
treatment, and prevention; pillar 2 on ways to tackle 
socioeconomic factors (eg, poverty reduction, social 
protection, and universal access); and pillar 3 on scientific 
research.
The second key document, published in 2016, sets 
out the UN’s Sustainable Development Goals (SDGs), 
replacing the Millennium Developing Goals. There are 
13 SDGs. SDG 3 is to ensure healthy lives and promote 
wellbeing for all at all ages. Within SDG 3 are several 
subtargets,2 including ending the epidemics of HIV, 
tuberculosis, malaria, and neglected tropical diseases, 
and combating hepatitis, waterborne, and other 
communicable diseases by 2030. SDG 1 is aimed at 
ending extreme poverty in all its forms everywhere. 
The WHO’s End TB Strategy and the UN’s SDGs are 
clearly connected because the End TB Strategy specifies 
indicators, targets, and strategic thinking necessary for 
elimination of one of the three pandemics specified in 
SDG 3. Additionally, one of the three main indicators of 
the End TB strategy—namely, reducing costs by 100% by 
20353—is directly associated with SDG 1.
The relation between poverty and disease is well 
known, and tuberculosis has provided a striking 
example throughout human history. Even in settings 
where tuberculosis treatment is cost-free, it has still 
been shown to generate catastrophic costs, so that 
individuals with lower resources have worse outcomes.4
Although it is methodologically complex to show 
the causal association between single interventions 
aimed at improving socioeconomic conditions and 
global tuberculosis incidence,5 the large decrease in 
tuberculosis incidence that occurred throughout the 
20th century is unlikely to have happened without 
the advancement of living conditions and overall 
socioeconomic development.6,7 Historical studies show 
the relation between tuberculosis and poverty; the 
important reduction in tuberculosis incidence achieved, 
such as the 10% reduction achieved per year in Europe 
after World War 2, was largely due to the improvement 
of the socioeconomic conditions.5,7 To quantify this 
association, poverty has been defined in the scientific 
literature by various different indicators, mostly with 
economic measures of individual or household income. 
SDG 1 introduces new concepts and indicators. Among 
them are social protection schemes, which aim to alleviate 
general poverty, vulnerability, and social exclusion. 
Higher spending on social protection programmes has 
been shown to be associated with lower tuberculosis 
prevalence, incidence, and mortality.8 Social protection 
includes measures designed to reduce vulnerability 
to poverty, labour market interventions, contributory 
welfare programmes, and cash transfers. SDG 1 subtargets 
are linked to the four main risk factors for tuberculosis 
(malnutrition, HIV, health behaviours, and housing 
quality), which directly affect tuberculosis incidence.
In The Lancet Global Health, Daniel J Carter and 
colleagues9 modelled the effects of social protection 
and poverty elimination to quantify tuberculosis 
incidence reduction. The authors developed a conceptual 
framework linking the core indicators of SDG 1 to 
tuberculosis incidence using a pathway of risk factors and 
real WHO data from 192 countries. The results show that 
the achievement of the goals in these two subtargets, 
even on their own, will greatly affect the tuberculosis 
epidemic. Ending extreme poverty (living on less than 
US$1·90) is estimated to reduce global tuberculosis 
incidence by 33·4% (95% credible intervals 15·5–44·5) 
and expanding social protection is estimated to reduce 
the incidence by 76·1% (45·2–89·9); achievement of 
both pathways is estimated to reduce incidence by 84·3% 
(54·7–94·9). These results, which highlight the clear need 
for multisectoral approaches to tackle global pandemics, 
have major policy implications and suggest the need for 
monitoring their implementation at the country level.
In Moscow, in November, 2017, WHO organised 
the Global Inter-Ministerial Conference on Ending 
Tuberculosis, which had the unprecedented 
participation of Ministries of Health from all over the 
world. The key message from the conference was that 
the tuberculosis services (under the Ministry of Health of 
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each country) need to work in strict collaboration with 
other ministries dealing with socioeconomic issues.
Thanks largely to WHO, the technical elements 
of tuberculosis control and elimination are now 
established throughout most of the world: active 
case-finding, effective diagnosis and treatment of 
infectious cases, and management of latent tuberculosis 
infection.10 The statistical model presented by Carter and 
colleagues9 underlines the need to tackle socioeconomic 
determinants just as vigorously as these technical 
elements if we are to see the final demise of tuberculosis 
throughout the world.
*Giovanni Battista Migliori, Alberto L Garcia-Basteiro
World Health Organization Collaborating Centre for Tuberculosis 
and Lung Diseases, Maugeri Care and Research Institute, IRCCS, 
Tradate, 21049, Italy (GBM); Centro de Investigação em Saude de 
Manhiça, Vila da Manhiça, Maputo Province, Mozambique (ALG-B); 
Amsterdam Institute for Global Health and Development, Academic 
Medical Center, Amsterdam, Netherlands (ALG-B); and ISGlobal, 
Hospital Clínic, Universitat de Barcelona, Barcelona, Spain (ALG-B) 
giovannibattista.migliori@icsmaugeri.it
We declare no competing interests.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access 
article under the CC BY-NC-ND 4.0 license. 
1 Sotgiu G, Spanevello A, Migliori GB. History of tuberculosis and drug 
resistance. N Engl J Med 2013; 368: 88–89.
2 UN. SDG indicators. https://unstats.un.org/sdgs/metadata/ (accessed 
March 13, 2018).
3 Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden 
for tuberculosis patients in low- and middle-income countries: 
a systematic review. Eur Respir J 2014; 43: 1763–75.
4 Wingfield T, Boccia D, Tovar M, et al. Defining catastrophic costs and 
comparing their importance for adverse tuberculosis outcome with multi-
drug resistance: a prospective cohort study, Peru. PLoS Med 2014; 
11: e1001675.
5 Grange JM, Gandy M, Farmer P, Zumla A. Historical declines in tuberculosis: 
nature, nurture and the biosocial model. Int J Tuberc Lung Dis 2001; 
5: 208–12.
6 Hermans S, Horsburgh CR Jr, Wood R. A century of tuberculosis 
epidemiology in the northern and southern hemisphere: the differential 
impact of control interventions. PLoS One 2015; 10: e0135179.
7 Wilson LG. The historical decline of tuberculosis in Europe and America: its 
causes and significance. J Hist Med Allied Sci 1990; 45: 366–96.
8 Siroka A, Ponce NA, Lönnroth K. Association between spending on social 
protection and tuberculosis burden: a global analysis. Lancet Infect Dis 
2016; 16: 473–79
9 Carter DJ, Glaziou P, Lönnroth K, et al. The impact of social protection and 
poverty elimination on global tuberculosis incidence: a statistical modelling 
analysis of Sustainable Development Goal 1. Lancet Glob Health 2018; 
published online March 23. http://dx.doi.org/10.1016/S2214-
109X(18)30195-5.
10 Gilpin C, Korobitsyn A, Migliori GB, Raviglione MC, Weyer K. The World 
Health Organization standards for tuberculosis care and management. 
Eur Respir J (in press).
